Samuel R. Chapin
Samuel R. Chapin's purchase track record
Samuel R. Chapin has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/5/2023 | PHIN | $115K | -3.8% | +24.8% | +12.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
UBS Downgrades O-I Glass to Neutral, Cuts Price Target to $6. UBS has downgraded O-I Glass to Neutral and lowered its price target to $6. This move places the new target near the bottom of the current analyst range. The stock is currently trading with an RSI of 28.7, indicating it is in oversold territory.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Revvity Announces Earnings Call, Analysts Upgrade Rating. Revvity has announced that it will conduct an earnings call on November 3, 2026. Analysts have upgraded the stock’s rating, citing stronger fundamentals and a positive outlook. Today’s trading saw unusual volume and the price is near its support level of $110.97 with an RSI of 68.9, indicating a moderately overbought condition.
Transaction History
| PHIN | ▲ Buy | Grant | 10 | $0 | 9/18/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 8 | $0 | 6/23/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 2,140 | $0 | 5/22/2026 | View on chart |
| OI | ▲ Buy | Open Market | 12,000 | $102K | 5/15/2026 | View on chart |
| OI | ▲ Buy | Grant | 18,038 | $0 | 5/14/2026 | View on chart |
| RVTY | ▲ Buy | Grant | 1,015 | $0 | 5/7/2026 | View on chart |
| RVTY | ▲ Buy | Grant | 1,265 | $0 | 5/7/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 3/20/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 12/12/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 15 | $0 | 9/12/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 21 | $0 | 6/16/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 3,299 | $0 | 5/21/2025 | View on chart |
| OI | ▲ Buy | Grant | 11,713 | $0 | 5/15/2025 | View on chart |
| RVTY | ▲ Buy | Grant | 1,074 | $0 | 4/30/2025 | View on chart |
| RVTY | ▲ Buy | Grant | 1,338 | $0 | 4/30/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 21 | $0 | 3/14/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 12/13/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 18 | $0 | 9/13/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 20 | $0 | 6/14/2024 | View on chart |
| OI | ▲ Buy | Grant | 10,933 | $0 | 5/16/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 3,261 | $0 | 5/9/2024 | View on chart |
| RVTY | ▲ Buy | Grant | 977 | $0 | 5/1/2024 | View on chart |
| RVTY | ▲ Buy | Grant | 1,218 | $0 | 5/1/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 90 | $0 | 3/15/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 114 | $0 | 12/15/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 125 | $0 | 9/22/2023 | View on chart |
| PHIN | ▲ Buy | Open Market | 4,000 | $115K | 9/5/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 8,142 | $0 | 7/18/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 4,749 | $0 | 7/18/2023 | View on chart |
| RVTY | ▲ Buy | Grant | 783 | $0 | 5/15/2023 | View on chart |
| RVTY | ▲ Buy | Grant | 955 | $0 | 5/15/2023 | View on chart |
| OI | ▲ Buy | Grant | 6,683 | $0 | 5/10/2023 | View on chart |
| OI | ▲ Buy | Grant | 10,802 | $0 | 5/11/2022 | View on chart |
| RVTY | ▲ Buy | Grant | 610 | $0 | 5/6/2022 | View on chart |
| RVTY | ▲ Buy | Grant | 744 | $0 | 5/6/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
UBS Lowers PHIN Target to $68, Keeps Neutral Rating
UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.
UBS Lowers PHIN Target to $68, Keeps Neutral Rating. UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.